Description

AGPV, a tetrapeptide, has the potential for prevention of schistosome parasite infection research[1].—COVID-19-immunoregulation–C15H26N4O5—-[1]James H. McKerrow, et al. Synthetic tetrapeptides for the prevention of schistosome parasite infection. US5284829A.–154485-78-6–342.39—-CC(C)[C@@H](C(O)=O)NC([C@H]1N(CCC1)C(CNC([C@@H](N)C)=O)=O)=O–Infection–10 mM in DMSO–Parasite–Schistosome–Anti-infection–Peptides